|
|
|
|
|
|
|
|
|
|
MabCure Announces Agreement with the City University of New York Center for Advanced Technology to Validate and Evaluate Its Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagents - MarketWatch
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”Albert Einstein
ovarian cancer
Ovarian Cancer Awareness (teal)
ovarian cancer
Ovarian Cancer
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.